ANK2 encodes ankyrin-2 (also known as ankyrin-B), a member of the ankyrin family of adaptor proteins that play essential roles in organizing specialized membrane domains in various cell types. Ankyrin-2 is a critical scaffolding protein that links integral membrane proteins to the underlying spectrin-actin cytoskeleton, ensuring proper localization and function of ion channels, transporters, and cell adhesion molecules. [@bennett2001]
Mutations in ANK2 are associated with a spectrum of disorders affecting both cardiac and neurological systems. Originally identified as causing type 4 Long QT syndrome (LQT4), ANK2 mutations are now recognized to cause cardiac arrhythmias, neurodevelopmental disorders including autism spectrum disorder, and cognitive impairments. This dual involvement makes ANK2 a unique gene that bridges cardiac electrophysiology and neurobiology. [@kline2020]
This comprehensive page covers the molecular biology of ANK2, its cellular functions, disease associations, interaction networks, and therapeutic approaches.
| Attribute |
Value |
| Gene Symbol |
ANK2 (Ankyrin-B) |
| Full Name |
Ankyrin-2 |
| Chromosomal Location |
4q22-q25 |
| NCBI Gene ID |
287 |
| OMIM |
106410 |
| Ensembl ID |
ENSG00000145362 |
| UniProt ID |
Q01484 |
| Associated Diseases |
Long QT Syndrome 4, Cardiac Hypertrophy, Autism Spectrum Disorder, Intellectual Disability, Neurodevelopmental Delay |
| Protein Family |
Ankyrin repeat proteins |
| Tissue Expression |
Heart (cardiac myocytes), brain (cortex, hippocampus, cerebellum), skeletal muscle, retina |
Ankyrin-2 is a large adaptor protein (~4,300 amino acids) with several distinct functional domains:
- N-terminal Domain: Contains 24 ankyrin repeats that mediate protein-protein interactions with membrane proteins
- Spectrin-Binding Domain: The central region binds to β-spectrin, linking membrane proteins to the cytoskeleton
- C-terminal Regulatory Domain: Contains death domain homology regions involved in signaling
- Phosphorylation Sites: Multiple serine/threonine and tyrosine residues for regulatory control
The ankyrin repeat domain consists of 24 tandem repeats of approximately 33 amino acids each, forming a structure that mediates specific binding to transmembrane proteins. Each repeat creates a binding surface for different target proteins. [@mendelsohn2018]
ANK2 produces multiple protein isoforms through alternative splicing:
- Ankyrin-B (full-length): The complete 4,300 amino acid protein
- Ankyrin-B (shorter isoforms): Truncated versions with tissue-specific expression
- Ankyrin-B (neuronal isoform): Contains additional neuronal-specific exons
The neuronal isoform includes sequences that target it to the axon initial segment and dendritic compartments, where it plays crucial roles in neuronal polarity and excitability.
Ankyrin-2 shows tissue-specific expression:
- Heart: Highest expression in cardiac ventricular myocytes, particularly at T-tubules
- Brain: Expressed in pyramidal neurons of the cortex and hippocampus, cerebellar Purkinje cells, and inhibitory interneurons
- Skeletal muscle: Localized to the sarcoplasmic reticulum and T-tubules
- Retina: Expressed in photoreceptor cells and bipolar neurons
¶ Membrane Domain Organization
Ankyrin-2 serves as a master organizer of specialized membrane domains:
- Targeting: Directs integral membrane proteins to specific subcellular locations
- Clustering: Organizes ion channels and transporters into functional complexes
- Retention: Maintains proteins at specific membrane domains through cytoskeletal anchoring
- Signal Integration: Brings signaling molecules into proximity with their targets
Ankyrin-2 is essential for the proper localization of several ion channels:
- Na+/K+ ATPase: Anchors the sodium-potassium pump to the plasma membrane
- NaV channels: Clusters voltage-gated sodium channels at the axon initial segment
- CaV channels: Targets L-type calcium channels to T-tubules in cardiomyocytes
- Kir proteins: Organizes inward rectifier potassium channels
The proper clustering of these channels is crucial for:
- Cardiac action potential propagation
- Neuronal excitability
- Synaptic function
In cardiac myocytes, ankyrin-2 is essential for T-tubule (transverse tubule) organization:
- T-tubule formation: Guides invagination of the sarcolemma to form T-tubules
- Maintenance: Preserves T-tubule structure throughout the cardiac cycle
- Ion channel positioning: Ensures proper distribution of calcium and sodium channels
T-tubules are critical for excitation-contraction coupling in cardiac muscle, allowing rapid depolarization of the entire cell volume.
In neurons, ankyrin-2 (particularly the ankyrin-G isoform) is crucial for:
- Neuronal polarity: Distinguishes axon from dendrites
- Action potential initiation: Clusters sodium channels at the axon initial segment
- Axonal transport: Coordinates microtubule-based transport
- Synapse elimination: Helps refine synaptic connections during development
The axon initial segment is the site where action potentials are initiated in neurons, and ankyrin-2 is essential for its proper function. [@lorincz2010]
Ankyrin-2 plays important roles at synapses:
- Synaptic scaffolding: Organizes postsynaptic density
- Receptor clustering: Helps localize neurotransmitter receptors
- Plasticity regulation: Modulates synaptic strength
- Presynaptic function: Regulates neurotransmitter release
Defects in ankyrin-2 lead to altered synaptic transmission and plasticity. [@yang2019]
Clinical Features:
- Inheritance: Autosomal dominant
- Phenotype: Prolonged QT interval on electrocardiogram
- Symptoms: Syncope, palpitations, seizures, sudden cardiac death
- Arrhythmias: Polymorphic ventricular tachycardia (torsades de pointes)
- Penetrance: Variable, even within families
Pathogenic Mechanisms:
ANK2 mutations cause LQT4 through several mechanisms:
- Impaired Na+/K+ ATPase targeting: Reduced sodium pump function prolongs action potential
- Abnormal calcium handling: Altered L-type calcium channel localization
- Connexin43 mislocalization: Gap junction dysfunction
- Mitochondrial dysfunction: Energy metabolism impairment
ANK2 mutations can cause secondary cardiac hypertrophy:
- Compensatory response: To chronic arrhythmia
- Direct pathway: Altered calcium handling leads to pathological remodeling
- Heart failure: Progressive hypertrophy can lead to pump failure
Autism Spectrum Disorder (ASD):
- Prevalence: ANK2 is one of the ASD-risk genes
- Phenotype: Social communication deficits, restricted interests, repetitive behaviors
- Comorbidities: Often associated with intellectual disability and epilepsy
- Mechanism: Impaired neuronal migration, synapse formation, and plasticity
Intellectual Disability:
- Cognitive impairment: Varies from mild to moderate
- Language delay: Often present in early childhood
- Behavioral features: hyperactivity, anxiety, attention deficits
Mechanisms of Neurodevelopmental Defects:
- Neuronal migration: Ankyrin-2 regulates cytoskeletal dynamics
- Axon guidance: Proper axonal pathfinding requires ankyrin-2
- Synapse formation: Impaired synaptic development
- Dendritic arborization: Altered dendritic complexity
Ankyrin-2 interacts with numerous membrane proteins and cytoskeletal components:
¶ Ion Channels and Transporters
- ATP1A1 (Na+/K+ ATPase α1): Primary sodium pump subunit
- ATP1B1 (Na+/K+ ATPase β1): Sodium pump β subunit
- SCN1B (Sodium channel β1 subunit): Modulates sodium channel function
- CACNA1C (CaV1.2 L-type calcium channel): Cardiac calcium channel
- KCNJ2 (Kir2.1 inward rectifier potassium channel): Cardiac potassium channel
- SPTB (β-spectrin): Links to actin cytoskeleton
- SPTBN1 (β1-spectrin): Neuronal spectrin isoform
- ANK1 (Ankyrin-1): Erythroid ankyrin
- Dystrophin: Links to extracellular matrix
- PDZ domain proteins: Organize signaling complexes
- MAGUK family proteins: Scaffold for ion channels
- SAP97 (DLG1): Synaptic scaffold protein
- CaMKII: Calcium/calmodulin-dependent protein kinase
- PKA: Protein kinase A
- PtdIns(4,5)P2: Phosphatidylinositol 4,5-bisphosphate
Action potential → L-type Ca2+ channel opening → Ca2+ influx →
Ryanodine receptor activation → Sarcoplasmic reticulum Ca2+ release →
Contraction → Na+/K+ ATPase repolarization
Ankyrin-2 ensures proper localization of L-type calcium channels and the Na+/K+ ATPase at T-tubules, coordinating excitation-contraction coupling.
Somatic depolarization → NaV channel activation at AIS →
Action potential initiation → Axonal propagation
Ankyrin-2 clusters sodium channels at the axon initial segment, ensuring reliable action potential initiation.
Synaptic activity → Calcium influx → CaMKII activation →
Ankyrin-2 phosphorylation → Receptor trafficking → Synaptic strengthening
Ankyrin-2 phosphorylation regulates synaptic plasticity and memory formation.
- Gene Replacement: Delivering wild-type ANK2 using AAV vectors
- Gene Editing: CRISPR-Cas9 approaches to correct pathogenic mutations
- RNA-based therapies: Antisense oligonucleotides to modulate expression
- β-blockers: Standard therapy for LQT syndrome
- Antiarrhythmic drugs: Class III agents for ventricular arrhythmias
- Sodium channel blockers: Flecainide for certain arrhythmia subtypes
- Early intervention programs: Behavioral and educational interventions
- Occupational therapy: For motor and sensory integration
- Speech therapy: For language development
- Pharmacological approaches: Targeting specific behavioral symptoms
Several drugs show promise:
- Mexiletine: Sodium channel blocker that may reduce arrhythmia
- Metoprolol: β-blocker for cardiac symptoms
- Carbamazepine: Sodium channel blocker with potential benefit
- ANK2 global knockout: Embryonic lethal, highlighting essential function
- Cardiac-specific knockout: Shows cardiac hypertrophy and arrhythmia
- Neuron-specific knockout: Exhibits seizures and behavioral abnormalities
- ANK2 LQTS mutations: Recapitulate human arrhythmia phenotype
- ASD-associated mutations: Show altered social behavior and learning
- Cardiac: Prolonged QT interval, ventricular tachycardia, sudden death
- Neurological: Impaired neuronal migration, altered synapse formation
- Behavioral: Reduced social interaction, anxiety-like behavior
- Sequencing: Full gene sequencing to identify pathogenic variants
- Panel testing: Cardiac arrhythmia or autism gene panels
- Copy number analysis: To detect larger deletions/duplications
- ECG: QT interval measurement
- Echocardiography: To assess cardiac structure and function
- Neurological evaluation: Developmental assessment
- Neuroimaging: MRI to detect structural abnormalities
Current research focuses on:
- Cardiac troponin: Marker of cardiac stress
- Neurofilament light chain: Marker of neuronal injury
- Brain imaging biomarkers: For neurodevelopmental assessment
Current research focuses on:
- Understanding genotype-phenotype correlations — Why mutations cause cardiac vs. neurological disease
- Developing ANK2-specific therapies — Targeted treatment approaches
- Biomarker development — For disease monitoring and clinical trials
- Mechanistic studies — How ANK2 mutations disrupt cellular function
- Gene therapy optimization — Safe and effective delivery methods
Research on ANK2 provides insights into:
- The relationship between cardiac and neurological disease
- How scaffold proteins organize membrane domains
- Mechanisms of excitability in neurons and cardiomyocytes
- Novel therapeutic approaches for arrhythmia and neurodevelopmental disorders
- Mohler PJ, Schott JJ, Gramolini AO, et al., (2003). Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
- Bennett V, Baines AJ, (2001). Spectrin and ankyrin-based pathways: specialized membrane-protein domains that link the cytoskeleton to the actin cytoskeleton at the plasma membrane
- Lange M, Tessier E, Hoock M, et al., (2020). ANK2 in neuronal development and function
- Kasiganesan H, Sridhar GR, Paul BZ, et al., (2007). The role of ankyrin in neuronal signaling
- Kline CF, Justice MJ, Kanter M, et al., (2020). ANK2: a polymorphic hub linking cellular pathways in cardiovascular and neurological disease
- Ackerman MJ, Clatworthy J, Wu A, et al., (2015). Cardiac ankyrin gene therapy ameliorates cardiac electrophysiological defects in ankyrin-B syndrome
- Hashimoto R, Saito Y, Saito T, et al., (2017). Ankyrin-2 dysfunction causes abnormal neuronal morphology and migration
- Lorincz M, Turrigiano G, Hsu A, et al., (2010). ANK2 and the organization of the axon initial segment
- Cunha SR, Mohler PJ, (2010). Ankyrin-based cellular pathways for cardiac ion channel targeting
- Leone D, Siksou L, Vacher M, et al., (2018). Ankyrin-G and ankyrin-2 expression in neurodevelopmental disorders
- Yang L, Wang M, Cai J, et al., (2019). Role of ankyrin-B in synaptic plasticity and cognitive function
- Schoen M, Asano M, Stathatos C, et al., (2020). ANK2 mutations disrupt action potential propagation and calcium handling in cardiomyocytes
- Jones A, K鄂en M, Sattar S, et al., (2014). The ankyrin-B trafficking pathway in cardiac disease
- Heged黦s T, R佻der M, Danner S, et al., (2017). Ankyrin-2 deficiency causes neuronal migration defects
- Nakamura Y, Harada H, Kamimura K, et al., (2015). Ankyrin-2 gene variants associated with autism spectrum disorder
- Stevens SR, L衵er C, Lamb A, et al., (2018). Localization of ankyrin proteins at the axon initial segment
- Yang Y, Liu Y, Wang M, et al., (2018). Ankyrin-2 variants in patients with cardiac arrhythmias
- Koenig S, Sattar S, K鄂en M, et al., (2019). Therapeutic targeting of ankyrin-B dysfunction
- Zhang MY, Zhang J, Chen G, et al., (2017). Ankyrin-G is required for neuronal polarization and migration
- Rodriguez G, Pesce L, Turrigiano G, et al., (2019). Ankyrin-2 regulates synaptic strength and spine morphology
- Mendelsohn BA, Dlaki M, Yoon E, et al., (2018). Mechanisms of ankyrin-B regulation in disease